Skip to content
HomeLatest newsCaring & giving9 ways Johnson & Johnson is sharing its vision for good with the world
People given cataract surgeries by Himalayan Cataract Project, an organization devoted to eliminating preventable and curable blindness

9 ways Johnson & Johnson is sharing its vision for good with the world

For World Sight Day, we share stats about how the company is helping expand eye care across the globe through advocacy, education and sustainable innovation.

More than 1 billion people around the world are living with vision impairment because they don’t have access to eye care or treatment.

It’s a fact that Johnson & Johnson Vision is determined to help change, and one that’s even more apparent now that the COVID-19 pandemic has shined a spotlight on the health disparities that exist across the globe: According to the World Health Organization, the burden of eye conditions and vision impairment is far greater in people such as those with low incomes, ethnic minorities and indigenous populations.

Through partnerships and scientific innovation, Johnson & Johnson Vision is aiming to tackle these health hurdles while also focusing on ensuring a healthier planet for generations to come, by reducing its carbon footprint, limiting landfill contribution and protecting natural resources. Recently, for example, Johnson & Johnson Vision signed a 10-year power purchase agreement with a solar farm to cover 100% of the electricity consumption of its headquarters in Jacksonville, Florida.

Here, key highlights from the Johnson & Johnson Vision 2020 impact report, Vision for Good, which launched this month and details the strides the company has already made toward these goals.


vc-infographic-final-0602.png

Read the 2020 Johnson & Johnson Vision Impact Report

Access the full report to learn more about how the company is working to improve vision around the world.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.